Ghost Tree Capital, LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 260 filers reported holding SAGE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 2.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
Ghost Tree Capital, LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$2,246,000
+20.3%
30,000
-53.8%
0.53%
+6.7%
Q1 2020$1,867,000
-82.8%
65,000
-56.7%
0.50%
-76.0%
Q4 2019$10,829,000
-29.8%
150,000
+36.4%
2.06%
-47.6%
Q3 2019$15,432,000
+180.9%
110,000
+266.7%
3.93%
+245.2%
Q2 2019$5,493,000
-54.0%
30,000
-60.0%
1.14%
-63.5%
Q1 2019$11,929,000
+273.9%
75,000
+125.2%
3.12%
+169.2%
Q4 2018$3,190,000
+137.7%
33,300
+250.5%
1.16%
+306.3%
Q3 2018$1,342,000
-24.9%
9,500
-14.4%
0.28%
-21.3%
Q1 2018$1,788,000
-83.4%
11,100
-83.0%
0.36%
-85.6%
Q4 2017$10,745,000
+15.0%
65,237
-56.5%
2.52%
+27.0%
Q3 2017$9,345,000
+134.7%
150,000
+200.0%
1.98%
+139.6%
Q2 2017$3,982,000
-44.0%
50,000
-50.0%
0.83%
-37.5%
Q1 2017$7,107,000
-30.4%
100,000
-50.0%
1.32%
-46.1%
Q4 2016$10,212,000
+26.7%
200,000
+14.3%
2.46%
+88.1%
Q3 2016$8,059,000
+78.3%
175,000
+16.7%
1.31%
+0.2%
Q2 2016$4,520,000
-11.9%
150,000
-6.2%
1.30%
-55.0%
Q1 2016$5,130,000
-56.0%
160,000
-20.0%
2.90%
-39.2%
Q4 2015$11,660,000
+575.2%
200,000
+390.2%
4.77%
+514.4%
Q3 2015$1,727,000
-73.5%
40,800
-54.3%
0.78%
-63.2%
Q2 2015$6,512,000
-46.0%
89,200
-62.8%
2.11%
-2.7%
Q1 2015$12,056,000240,0002.17%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 5,149,482$105,976,3402.24%
Palo Alto Investors LP 1,005,776$20,698,8701.96%
Boxer Capital, LLC 1,094,000$22,514,5201.20%
Bellevue Group AG 3,513,351$72,304,7641.16%
PDT Partners, LLC 181,625$3,737,8430.47%
EASTERLY INVESTMENT PARTNERS LLC 195,643$4,026,3330.44%
Harvest Investment Services, LLC 30,302$623,6150.40%
Simplify Asset Management Inc. 120,030$2,470,2170.28%
SAMLYN CAPITAL, LLC 739,867$15,226,4630.25%
CAXTON ASSOCIATES LP 68,035$1,400,1600.19%
View complete list of SAGE THERAPEUTICS INC shareholders